Doctor profile · Federal record
Dr. Ute Dreiner, M.D.
Rheumatology Physician (CMS: Rheumatology) · New Hartford, NY
- NPI 1114914421
- Accepts Medicare
- 40 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1729 Burrstone RD
New Hartford, NY 134131001
(315) 798-1700
fax (315) 798-1707
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- December 7, 2012
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New York #193606
- Medicaid
- NY #01435230
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114914421. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,172
Distinct HCPCS
9
Medicare allowed
$438,459
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 6,000 | 12 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,175 | 11 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,330 | 16 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,226 | 622 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 159 | 122 | $120 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 87 | 19 | $27 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 79 | 26 | $124 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 77 | 22 | $61 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 39 | 39 | $160 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 1,759. This provider delivers 7.5× the peer median.Open Payments
Industry payments received
All-time total
$1,202
Transactions
64
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| UCB, Inc. | 17 | $320.04 | |
| ABBVIE INC. | 16 | $230.99 | |
| Novartis Pharmaceuticals Corporation | 7 | $158.67 | |
| PFIZER INC. | 5 | $107.50 | |
| Janssen Biotech, Inc. | 4 | $87.72 | |
| Amgen Inc. | 4 | $86.41 | |
| Genentech USA, Inc. | 4 | $72.68 | |
| Lilly USA, LLC | 3 | $63.32 | |
| AstraZeneca Pharmaceuticals LP | 1 | $22.70 | |
| Organon Llc | 1 | $21.00 | |
| GlaxoSmithKline, LLC. | 1 | $17.39 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $14.05 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,614
Patients
559
Total drug cost
$681,323
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 319 | 111 | $3,511 |
| Methotrexate (Methotrexate Sodium) | Brand | 266 | 109 | $11,287 |
| Hydroxychloroquine Sulfate | Generic | 262 | 100 | $12,819 |
| Gabapentin | Generic | 161 | 63 | $3,328 |
| Duloxetine Hcl | Generic | 133 | 59 | $6,624 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 68 | 24 | $3,674 |
| Celecoxib | Generic | 57 | 20 | $6,189 |
| Leflunomide | Generic | 56 | 27 | $7,760 |
| Allopurinol | Generic | 49 | 16 | $848 |
| Pregabalin | Generic | 49 | 11 | $1,674 |
Hospital affiliations
Frequently asked questions
What is Dr. Ute Dreiner's medical specialty?
Dr. Ute Dreiner practices Rheumatology Physician in New Hartford, NY.
Where does Dr. Ute Dreiner practice?
Dr. Ute Dreiner practices at 1729 Burrstone RD, New Hartford, NY 134131001. Office phone: 3157981700.
What is Dr. Ute Dreiner's NPI?
Dr. Ute Dreiner's National Provider Identifier (NPI) is 1114914421, issued by NPPES.
Does Dr. Ute Dreiner accept Medicare assignment?
Yes. Dr. Ute Dreiner accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ute Dreiner commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.